Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.75 USD | -0.36% | +2.30% | +16.35% |
May. 09 | Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q1 Revenue $98,000 | MT |
May. 09 | VYNE Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.35% | 38.91M | |
+33.85% | 709B | |
+31.14% | 595B | |
-2.09% | 367B | |
+20.60% | 334B | |
+5.07% | 289B | |
+14.45% | 239B | |
+9.24% | 211B | |
-3.48% | 203B | |
+8.48% | 171B |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- Transcript : Foamix Pharmaceuticals Ltd., Menlo Therapeutics Inc. - M&A Call